Corporate governance overhang haunts Sun Pharma despite management rebuttal


Corporate governance overhang haunts Sun Pharma despite management rebuttal Sun Pharma has been trying to restore investor confidence, after a scathing note by Australian brokerage firm Macquarie and a whistleblower complaint to the Securities and Exchange of India (SEBI) last week, the drug maker stock since then dropped one-fifth of its value.